Directory
>
Emil Kuriakose Md
Emil Kuriakose Md
Chief Medical Officer | Terns Pharmaceuticals
Houston, Texas, United States
Emil Kuriakose Md
Summary
Emil Kuriakose is a board-certified hematologist and oncologist with extensive experience in clinical development and medical affairs, particularly within oncology. Currently serving as the Chief Medical Officer at Terns Pharmaceuticals, he has a proven track record in leading innovative clinical research and managing complex clinical trials from early to late phases. Emil's expertise spans various areas including regulatory submissions, investor relations, and strategic team leadership. He has held significant roles in both large pharmaceutical companies and smaller biotech firms, contributing to groundbreaking therapies in hematologic and solid tumors. His academic background includes training at prestigious institutions like Cornell and MSKCC, positioning him as a thought leader in the field. Emil is also passionate about advancing public health initiatives and enhancing patient care through collaborative efforts in the medical community.
Emil Kuriakose Md
Work Experience
Chief Medical Officer at
Terns Pharmaceuticals
August 2023 - Present
Chief Medical Officer, Oncology at
Terns Pharmaceuticals
March 2023 - Present
Chief Medical Officer at
Calithera Biosciences
November 2021 - March 2023
Vice President, Clinical Development at
Calithera Biosciences
February 2020 - November 2021
Vice President, Head of Clinical Development at
Calithera Biosciences
January 2021 - November 2021
Senior Medical Director at
Calithera Biosciences
October 2017 - February 2020
Global Clinical Program Lead at
Novartis
January 2016 - September 2017
Medical Director at
Novartis Oncology
July 2013 - January 2016
Hematology/Oncology Fellow at
Weill Cornell Medicine
July 2010 - June 2013
Research Fellow at
Memorial Sloan Kettering Cancer Center
June 2011 - June 2013
Attending Hospitalist at
Dallas Va Medical Center
June 2009 - June 2010
Resident physician at
Ut Southwestern Medical Center
July 2006 - June 2009
Emil Kuriakose Md
Education
SUNY Stony Brook Medical Center, Doctor Of Medicine (Md)
Frequently Asked Questions about Emil Kuriakose Md
What is Emil Kuriakose Md email address?
Emil Kuriakose Md's primary email address is **********@ternspharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Emil Kuriakose Md work for?
Emil Kuriakose Md is a Chief Medical Officer at Terns Pharmaceuticals, a company specializing in Biological products, except diagnostic.
Where Emil Kuriakose Md graduated from?
Emil Kuriakose Md holds a degree in Neural Science from New York University.
How can I directly contact Emil Kuriakose Md?
To contact Emil Kuriakose Md directly, you can use the email address **********@ternspharma.com. Complete contact information is available upon registration with Muraena.
Who is Emil Kuriakose Md?
Emil Kuriakose is a board-certified hematologist and oncologist with extensive experience in clinical development and medical affairs, particularly within oncology. Currently serving as the Chief Medical Officer at Terns Pharmaceuticals, he has a proven track record in leading innovative clinical research and managing complex clinical trials from early to late phases. Emil's expertise spans various areas including regulatory submissions, investor relations, and strategic team leadership. He has held significant roles in both large pharmaceutical companies and smaller biotech firms, contributing to groundbreaking therapies in hematologic and solid tumors. His academic background includes training at prestigious institutions like Cornell and MSKCC, positioning him as a thought leader in the field. Emil is also passionate about advancing public health initiatives and enhancing patient care through collaborative efforts in the medical community.
Emil`s contact details
**********@ternspharma.com
Colleagues
Senior Vice President
President and Head of Research and Development
Chief Business Officer
Executive Director, Clinical Operations
Board Member
SVP, Medical Affairs
Chief Executive Officer
VP, Program and Alliance Management
Senior Vice President, Research